Rite Aid Corp. (RAD), one of the nation's leading drugstore chains, reported yet another month of poor same-store sales. After falling 1.7% in October 2010, same-store sales slipped by 1.3% in November. This marks the 18th consecutive month of decline -- since May 2009, when it had registered positive same-store sales of 0.6%.
For the month under review, Rite Aid posted sales of $2,370 million, down 2.3% from the year-ago month.
Front-End Same-Store Sales
As per the company, front-end same-stores sales increased 1.3% in November 2010, a sharp jump from a moderate slide of 1.3% in October 2010.
Prescription Same-Store Sales
Prescription registered a 1.9% cut in same-store sales in November 2010 compared with a reduction of 1.9% in October and 1.3% in September.
Pharmacy Same Store Sales
The company acknowledged that pharmacy same-store sales dropped 2.5% in November 2010, after recording marginal declines of 1.8% and 1.2% in October and September, respectively. Rite Aid said that the introduction of new generic drugs pulled down pharmacy's November same-store sales by 248 basis points.
Quarterly Sales
For the thirteen weeks ended November 27, 2010, same-store sales tumbled 1.3% with Front-End, Pharmacy and Prescription recording flat growth, decline of 1.9% and fall of 1.7%, respectively. Total drugstore sales for the thirteen-week period were $6,180 million compared with $6,329 million in the prior-year period.
Guidance
Rite Aid, the operator of 4,731 drug stores, now expects total sales between $25 billion and $25.4 billion for fiscal 2011. Same-stores sales for fiscal year 2011 are expected in the range of negative 1.5% to break-even.
The company operates in a highly fragmented specialty retail sector and faces intense competition from CVS Caremark Corporation (CVS), Walgreen Co. (WAG) and Wal-Mart Stores Inc. (WMT).
Rite Aid's shares maintain a Zacks #3 Rank, which translates into a short-term Hold recommendation. Our long-term recommendation for the stock remains Neutral.
CVS CAREMARK CP (CVS): Free Stock Analysis Report
RITE AID CORP (RAD): Free Stock Analysis Report
WALGREEN CO (WAG): Free Stock Analysis Report
WAL-MART STORES (WMT): Free Stock Analysis Report
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.